Biotalys Reports Full-Year 2025 Financial Results and Business HighlightsUnusual Whales·Apr 29 at 12:01 AMBTAI-2.32%TBIO0.00%
Terremoto wins $108m in Series C to drive cancer and rare disease programmesPharmaceutical Technology·Apr 16 at 04:39 AMTBIO0.00%MBX-4.55%
Telesia Extends Timetable for 2025 Accounts and Updates 2026 Financial CalendarTip Ranks·Mar 17 at 09:52 AMLABU+2.48%IBB+0.87%
Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026Tip Ranks·Mar 10 at 06:28 AMXBI+0.74%ASMB+0.36%
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular DystrophyTip Ranks·Feb 18 at 01:27 PMTBIO0.00%XBI+0.74%
GeminiBio partners with Tolemy Bio to launch aiMOS™, the first AI-enabled media optimization service for cell therapy.Unusual Whales·Feb 10 at 06:45 AMFBT+0.76%ARKG+1.28%
Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States | MSLE Stock NewsStockTitan·Feb 5 at 11:30 PMPBE+0.17%FBT+0.76%
